Date published: 2026-5-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

β-Arrestin-1 Inhibitors

β-Arrestin-1 Inhibitors are a class of compounds that have garnered significant attention within the realm of cell signaling. These molecules are specifically designed to modulate the activity of β-arrestin-1, a key intracellular protein involved in regulating G-protein-coupled receptor (GPCR) signaling pathways. GPCRs, a diverse group of cell surface receptors, play a pivotal role in transmitting extracellular signals to intracellular responses. β-arrestin-1, traditionally considered as a terminator of GPCR signaling through desensitization and internalization, has now been recognized for its role in initiating alternative pathways, distinct from those triggered by G proteins. β-Arrestin-1 inhibitors operate by selectively binding to β-arrestin-1 and inhibiting its interaction with GPCRs, effectively dampening or redirecting downstream signaling cascades. The design and development of these inhibitors require a deep understanding of the structural and functional aspects of β-arrestin-1 and its interactions with GPCRs.

Researchers have employed various strategies, including virtual screening, structure-based drug design, and high-throughput screening, to identify compounds that can effectively hinder the association between β-arrestin-1 and GPCRs. Mechanistically, these inhibitors can modulate signaling pathways by preventing β-arrestin-1-mediated internalization of GPCRs, altering receptor trafficking, and impacting downstream signaling effectors. In summary, β-Arrestin-1 inhibitors represent a fascinating class of molecules aimed at elucidating the intricate complexities of GPCR signaling. By selectively targeting β-arrestin-1, these inhibitors provide researchers with a valuable tool to dissect the specific contributions of β-arrestin-1-mediated pathways in cellular responses. As the understanding of GPCR signaling continues to evolve, β-Arrestin-1 inhibitors hold the promise of offering insights into novel signaling paradigms, beyond the canonical G protein-dependent pathways, ultimately contributing to a more comprehensive comprehension of cellular communication and signal transduction.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bakuchiol

10309-37-2sc-202075
1 mg
$45.00
1
(1)

A natural compound found in plants, it has been shown to inhibit β-arrestin-1-mediated signaling pathways.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

While primarily a beta-blocker, it also exhibits some β-arrestin-1 inhibitory effects, affecting GPCR-mediated pathways.

Dexrazoxane

24584-09-6sc-252669
5 mg
$112.00
1
(1)

An agent with potential β-arrestin-1 inhibitory effects.

Pindolol

13523-86-9sc-204847
sc-204847A
100 mg
1 g
$194.00
$760.00
(1)

A beta-blocker with partial agonist activity, affecting β-arrestin-1-mediated signaling along with GPCR pathways.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

A non-selective beta-blocker with antioxidant properties that can influence β-arrestin-1-dependent signaling.

IC261

186611-52-9sc-3561
5 mg
$140.00
11
(1)

An ATP-competitive inhibitor that disrupts the activity of protein kinases, potentially impacting β-arrestin-1 pathways.

PF-3644022

1276121-88-0sc-478487
sc-478487A
5 mg
25 mg
$367.00
$2856.00
(0)

An experimental compound developed as a β-arrestin-1 inhibitor, targeting its interactions with GPCRs.

Ambrisentan

177036-94-1sc-207276
5 mg
$348.00
(0)

While primarily used for pulmonary arterial hypertension, it has been investigated for its effects on β-arrestin-1 signaling.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

A natural polyphenol with potential β-arrestin-1 inhibitory effects, although its precise mechanism is still under study.